OBJECTIVE: Dyslipidaemia in obesity is characterized by hypertriglyceridaemia, low HDL-C levels, small, dense HDL particles and increased phospholipid transfer protein (PLTP) activity. METHODS: In the present study, we investigated PLTP activity and HDL particle size in 16 morbidly obese, middle-aged women, who underwent Swedish Adjustable Gastric Banding surgery. Study subjects were tested within 2 months before and 1 y after surgery. PLTP activity was determined by exogenous substrate assay and HDL particle size by gradient gel electrophoresis, respectively. RESULTS: Pronounced weight loss after gastric banding surgery resulted in a significant decrease of PLTP activity from 8.4272.04 to 7.4372.21 mmol/ml/h (P ¼ 0.02). The size of HDL 2 particles increased signficantly from 14.0470.86 to 14.2870.64 nm (P ¼ 0.02) after body weight reduction, while no change in HDL 3 particle size was apparent. DISCUSSION: Our results suggest that dyslipidaemia in obesity isFat least partiallyFreversible by weight loss. We hypothesize that reduction of PLTP activity and increase of HDL particle size are important component factors in converting the atherogenic lipoprotein profile of obese subjects into a less atherogenic profile with weight loss.
Introduction
Obesity is frequently associated with insulin resistance and dyslipidaemia characterized by hypertriglyceridaemia, low HDL levels, preponderance of small, dense LDL and HDL particles, and increased phospholipid transfer protein (PLTP) activity. 1 PLTP is a key enzyme in HDL metabolism by transferring phospholipids from triglyceride-rich lipoproteins to HDL on one hand and among HDL particles on the other, resulting in the conversion of HDL particles into larger particle species and the generation of pre-b HDL. 2, 3 Overexpression of PLTP is highly associated with a decrease in HDL levels, probably due to accelerated HDL catabolism. 4 In the present study, we investigated whether the reported increase of PLTP activity and known preponderance of small HDL particles in obesity, two markers that are thought to be risk factors for atherosclerosis, are reversible by weight loss.
Methods

Subjects
A total of 16 morbidly obese (BMI440 kg/m 2 ), middle-aged women who participated in a prospective study reported elsewhere 5 were investigated. In short, the exclusion criteria were secondary causes of obesity, diabetes mellitus, pregnancy, intake of lipid-lowering drugs or medically significant illness. Examinations of the study subjects were undertaken within 2 months before and 1 y after Swedish Adjustable Gastric Banding (SAGB) surgery. Body composition was determined by impedance analysis (BIA 2000-M Impedance Analyser, Data Input), lipoprotein analysis was performed as described. 5 Informed consent was obtained from each study subject, and all procedures were performed in accordance with institutional guidelines.
PLTP activity
The ability of plasma to transfer 3 H-dipalmitoyl-phosphatidylcholine (NEN Life Science Products, Boston, MA, USA) from phosphatidylcholine vesicles to HDL 3 was measured as described previously. 1 HDL gel electrophoresis HDL size was analysed by 4-20% gradient gel electrophoresis (Biorad, Vienna, Austria) as described elsewhere. 6 Statistical analysis Data are expressed as means7s.d. Statistical differences were determined by paired t-test. Statistical significance was inferred at a two-tailed P-value o0.05. SPSS for Windows (Version 11.0) was used for statistical analyses.
Results
Anthropomorphic characteristics and laboratory measurements before and after surgical intervention are summarized in Table 1 . Surgical intervention resulted in significant reductions of BMI by 24% and total body fat mass by 42%, respectively. Total HDL-C and HDL 2 -C levels were significantly higher, TG levels as well as fasting glucose and insulin concentrations were significantly lower after weight loss.
PLTP activity decreased significantly from 8.4272.04 mmol/ml/h before surgical intervention to 7.4372.21 mmol/ ml/h 1 y after SAGB (P ¼ 0.02). As shown in Figure 1 , the size of HDL 2 particles increased from 14.0470.86 to 14.2870.64 nm (P ¼ 0.02) after SAGB, while no significant change in HDL 3 particle size was found after surgical intervention (12.1770.64 vs 12.2070.80 nm; P ¼ 0.66). Size of HDL 3 particles was negatively correlated with PLTP activity before surgical intervention (r ¼ À0.69, P ¼ 0.02), while no correlation was found after SAGB. No correlation was found between the size of HDL 2 particles and PLTP activity.
Discussion
Obesity is thought to be a contributing or even independent risk factor for atherosclerosis. Dyslipidaemia associated with obesity is likely to contribute to the increased risk for atherosclerosis in obesity. Besides hypertriglyceridaemia, dyslipidaemia in obesity is also characterized by the preponderance of small, dense LDL and HDL particles and increased lipid transfer protein activities, namely PLTP and that in morbidly obese, middle-aged women, increased CETP activity is reversible by significant weight loss. Accordingly, the size of LDL particles was significantly increased after body weight reduction. 5 We, therefore, extended these studies by investigating whether increased PLTP activity and abnormalities in HDL size are also reversible by weight loss. PLTP activity was decreased after pronounced weight loss 1 y after SAGB in 16 morbidly obese, middle-aged women, suggesting that elevation of PLTP activity in obesity is reversible by weight loss. Consistent with data from several studies 7 showing positive correlations between PLTP activity and TG levels and negative associations with HDL-C levels, the decrease of PLTP activity was accompanied by a reduction in TG concentrations and an increase in HDL-C levels. We therefore suggest that, besides other mechanisms including decreases of CETP 5 and hepatic lipase activity, reduction in PLTP activity may also play a critical role in shifting an atherogenic into a less atherogenic lipoprotein profile after weight loss. When considering the in vitro data showing that PLTP converts HDL particles into larger particle species with a concomitant release of lipid-poor, apolipoprotein A-I-rich particles, 7 one would expect reduced PLTP activity to be associated with a decrease in HDL particle size. Indeed, we found that weight loss results in an increase in HDL particle size despite decreased PLTP activity, suggesting that reductions of CETP and hepatic lipase activity rather than PLTP activity affect HDL size in our study. Previously, Freedman et al 8 found that a predominance of small HDL particles is associated with increased atherosclerosis independently of prevailing lipid levels, suggesting that the reported increase in HDL 2 particle size presents another critical antiatherogenic effect of weight loss.
In conclusion, we found that pronounced weight reduction results in decreased PLTP activity, elevated HDL-C concentrations and increased HDL 2 particle size after weight loss. Our results support the hypothesis that dyslipidaemia in obesity is reversible by significant weight loss and that body weight reduction converts an atherogenic lipoprotein profile into a less atherogenic profile. 
